TABLE 2

Inhibitory activity of test compounds against mutant HIV-1 RTs (N136X)

Data are the mean (± S.D.) of at least three to four independent experiments.

RT Mutation IC50
Nevirapine Delavirdine Efavirenz Quinoxaline ddGTP
μM
WT 0.45 ± 0.25 0.31 ± 0.025 0.027 ± 0.006 0.022 ± 0.006 0.051 ± 0.009
N136T 1.0 ± 0.29 0.90 ± 0.16 0.035 ± 0.006 0.033 ± 0.004 0.065 ± 0.007
N136A >10 6.6 ± 2.4 0.21 ± 0.20 0.28 ± 0.01 0.28 ± 0.48
N136Q ≥10 4.5 ± 1.7 0.051 ± 0.018 0.39 ± 0.21 1.4 ± 0.20
N136S 5.1 ± 2.6 3.1 ± 1.7 0.052 ± 0.044 0.35 ± 0.32 0.58 ± 0.51
N136K >10 ≥10 0.16 ± 0.021 ≥1 0.93 ± 0.64
N136L >10 9.1 ± 1.3 0.13 ± 0.014 0.80 ± 0.021 6.1 ± 1.0
N136D 2.7 ± 2.3 1.3 ± 1.2 0.036 ± 0.0007 0.037 ± 0.002 0.19 ± 0.021
N136Y >10 >10 0.12 ± 0.01 ≥1 1.6 ± 0.32
  • Template/primer, poly(rC) · oligo(dG); substrate, 1.6 μM [3H]dGTP.